Skip to main content

and
  1. Article

    Open Access

    Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett’s esophagus

    In carcinogenesis, intercellular interactions within and between cell types are critical but remain poorly understood. We present a study on intercellular interactions between normal and premalignant epithelia...

    Jia Zeng, Laimonas Kelbauskas, Aida Rezaie, Kristen Lee in Scientific Reports (2016)

  2. Article

    Open Access

    Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells

    The histone deacetylase (HDAC) inhibitor vorinostat has received significant attention in recent years as an ‘epigenetic’ drug used to treat solid tumors. However, its mechanisms of action are not entirely und...

    Vivek Nandakumar, Nanna Hansen, Honor L. Glenn, Jessica H. Han in Scientific Reports (2016)

  3. Article

    Open Access

    Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

    Adrenocortical carcinoma (ACC) is an aggressive cancer with a 5 year survival rate of 20–30 %. Various factors have been implicated in the pathogenesis of ACC including dysregulation of the G2/M transition and...

    Kimberly J. Bussey, Aditi Bapat, Claire Linnehan in Clinical and Translational Medicine (2016)

  4. No Access

    Article

    Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4–ALK Translocation as a Therapeutic Target

    Recent advances in the treatment of cancer have focused on targeting genomic aberrations with selective therapeutic agents. In radioiodine resistant aggressive papillary thyroid cancers, there remain few effec...

    Michael J. Demeure, Meraj Aziz, Richard Rosenberg in World Journal of Surgery (2014)

  5. Article

    Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond

    Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cis...

    Michael J. Demeure, Kimberly J. Bussey, Lawrence S. Kirschner in Hormones and Cancer (2011)

  6. Article

    Open Access

    Mistaken Identifiers: Gene name errors can be introduced inadvertently when using Excel in bioinformatics

    When processing microarray data sets, we recently noticed that some gene names were being changed inadvertently to non-gene names.

    Barry R Zeeberg, Joseph Riss, David W Kane, Kimberly J Bussey in BMC Bioinformatics (2004)

  7. Article

    Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells

    Microarray gene-expression profiles are generally validated one gene at a time by real-time RT-PCR. We describe here a different approach based on simultaneous mutual validation of large numbers of genes using...

    Jae K Lee, Kimberly J Bussey, Fuad G Gwadry, William Reinhold in Genome Biology (2003)

  8. Article

    Open Access

    MatchMiner: a tool for batch navigation among gene and gene product identifiers

    MatchMiner is a freely available program package for batch navigation among gene and gene product identifier types commonly encountered in microarray studies and other forms of 'omic' research. The user inputs...

    Kimberly J Bussey, David Kane, Margot Sunshine, Sudar Narasimhan in Genome Biology (2003)

  9. Article

    Open Access

    GoMiner: a resource for biological interpretation of genomic and proteomic data

    We have developed GoMiner, a program package that organizes lists of 'interesting' genes (for example, under- and overexpressed genes from a microarray experiment) for biological interpretation in the context ...

    Barry R Zeeberg, Weimin Feng, Geoffrey Wang, May D Wang, Anthony T Fojo in Genome Biology (2003)